No Baby Blisters renews its 2026 campaign to provide life-saving medical supplies and fund research for children with Epidermolysis Bullosa (EB), a rare genetic blistering disease. To date, the organization has helped over 5,100 children worldwide who suffer from this devastating condition.

-- No Baby Blisters, a 501(c)(3) nonprofit dedicated to supporting children with Epidermolysis Bullosa (EB), redoubles its support for children with EB Blistering Skin disease through its 2026 awareness and fundraising campaign. The initiative addresses the urgent needs of children across five continents who suffer from EB, a rare genetic disease that causes skin to become so fragile it tears or blisters at the slightest touch. Without proper care, many infants do not survive their first year, while survivors face a life of chronic pain and infections.
More information is available at https://nobabyblisters.org/
The campaign targets medically neglected children living in poverty who lack access to essential care. EB is often overlooked by major organizations like St. Jude and UNICEF, leaving a critical gap in support. No Baby Blisters fills this void by facilitating, funding, and providing resources for treatment where no other help exists.
Donations will fund acute pain medication, specialized bandages, antibiotics, and wound-healing nutrition that prevent death and reduce daily suffering. The organization maintains a Platinum GuideStar rating—the highest level of transparency—and provides monthly updates on individual children to demonstrate direct donor impact. For example, Baby John, an infant born with extensive blistering, received emergency funding for specialized ointments that saved his leg and his life.
Beyond immediate relief, No Baby Blisters is pursuing a Fast Cure Plan designed to produce an affordable, full-body solution. This strategy focuses on systemic research to treat the whole body, gene therapy to address mutated proteins, and molecular research using natural ingredients to accelerate healing. Dr. Aaron Tabor, the charity's founder and an NIH-funded researcher, leads this effort to ensure a cure is accessible to all EB patients regardless of their economic status.
Dr. Tabor founded No Baby Blisters after discovering that thousands of children with EB are medically neglected in poverty, with no other charities intervening. His work, alongside clinical modalities developed by the charity's field teams, has been validated in NIH peer-reviewed literature. These publications reinforce that donations fund evidence-based care already recognized by the medical community.
The 2026 campaign aims to recruit new Hero Guardian Angels—monthly givers whose recurring contributions start as low as $3 per month. These recurring donations are critical to ensuring children never run out of life-saving supplies. As a US 501(c)(3) nonprofit, No Baby Blisters offers tax-deductible giving and transparent operations. Every contribution directly saves a child's life today while advancing a permanent cure for tomorrow.
"Our good-hearted, compassionate, and loving Monthly Donors are noble guardian angels of mercy for the forgotten, medically neglected children," Dr. Tabor said. "Working together, we guard the lives of the sickest, most disadvantaged children in the world, struggling in pain to stay alive."
For more details, visit https://nobabyblisters.org/
Contact Info:
Name: Aaron Tabor
Email: Send Email
Organization: No Baby Blisters
Address: 731 Chapel Hills Drive , Colorado Springs, Colorado 80920, United States
Website: https://nobabyblisters.org/
Source: PressCable
Release ID: 89183882
In case of detection of errors, concerns, or irregularities in the content provided in this press release, or if there is a need for a press release takedown, we strongly encourage you to reach out promptly by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our efficient team will be at your disposal for immediate assistance within 8 hours – resolving identified issues diligently or guiding you through the removal process. We take great pride in delivering reliable and precise information to our valued readers.


